Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
0.9998
-0.0102 (-1.01%)
At close: Apr 2, 2026, 4:00 PM EDT
0.9306
-0.0692 (-6.92%)
After-hours: Apr 2, 2026, 5:18 PM EDT
Tivic Health Systems Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
2.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 780.00K | -396.00K | -33.67% |
| Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
| Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
| Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.27M |
| INVO Fertility | 6.94M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.69M |
| Catheter Precision | 819.00K |
| Co-Diagnostics | 622.49K |
| iTonic Holdings | 523.03K |
TIVC News
- 3 days ago - Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod - Accesswire
- 7 days ago - Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference - Accesswire
- 8 days ago - Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome - Accesswire
- 9 days ago - Tivic Reports Full Year 2025 Results - Accesswire
- 10 days ago - Tivic Health CEO Letter to Shareholders - Accesswire
- 14 days ago - Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET - Accesswire
- 4 weeks ago - Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma - Accesswire
- 6 weeks ago - Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10 - Accesswire